Netherlands-based Parx Plastics says it has successfully added antimicrobial properties into German chemical firm BASF’s Terluran GP-35 ABS copolymer. Terluran is a standard ABS grade with a low viscosity with a very wide range of applications. ISO 22196 testing by a TÜV-certified laboratory show an antimicrobial effect of 98-99% for Escherichia Coli (Gram-) and Staphilococcus Aurus (Gram+) bacteria. Terluran GP-35 is a so called “world grade” material as it is available throughout the world and now with the aid of the patented technology of Parx Plastics it can incorporate an effective antimicrobial property.

The technology provided by Parx, a result of four years of biomimetic research, allows the creation of Sanipolymers by incorporating a bodily own trace element providing an effective antibacterial property. The technology can be applied to any (co-)polymer and offers a safe and non-toxic alternative to the presently available solutions such as (nano-)silver, chemicals (e.g. Triclosan) or solutions by means of nano-particles and is suitable for food and medical-grade materials. The effectiveness can reach as high as 98-99% after 24 hours following the ISO 22196 or JIS Z 2801 testing guidelines and works effectively against Staphylococcus Aureus, Escherichia Coli, MRSA, Clostridium Difficile and many others.

Parx says its technology is very appealing to many markets and applications as it shows no migration.